Merck’s new ‘not Ivermectin’ Covid-19 treatment, molnupiravir, costs $17.74 to produce – yet the company is charging the US government $712 for the treatment– a 40x markup, according to The Intercept, citing a report issued last week by the Harvard School of Public Health and King’s College Hospital in London.
A trio of scientists at Pfizer were recorded speaking to undercover reporters about the existence of natural immunity to the virus that causes COVID-19, with one saying employees had been told not to discuss the protection publicly.
Researchers in Italy have developed a physical system to mimic properties of human brains that they hope will massively reduce the power costs of neural networks fundamental to AI development.
A new study (Burkart et al., 2021) reports that for every 356 deaths attributable to warm weather across the globe there were 1,337 attributable to cold weather in 2019.
The mainstream media’s myopic focus on Israel’s Pegasus spyware and the threats it poses means that other companies, like Toka, go uninvestigated, even when their products present an even greater potential for abuse and illegal surveillance.
A patent issued for the purpose of contact tracing all vaccinated humans worldwide – “Wake up stupid little sheep. You are being led to your slaughter.”
You may recall that Dr. Robert Young was the man who made the claim based on his discovery that the COVID shots contained graphene oxide, parasites, stainless steel and other metals. On Wednesday, he made the claim that millions have died from these experimental shots.
A woman identified as the senior director of worldwide research, development and medical communications for Pfizer ran away from a reporter when confronted about an email she allegedly sent confirming fetal tissue lines were used in the testing of the company’s COVID-19 vaccine.
Ivermectin is a cheap, repurposed World Health Organization (WHO) approved parasitic drug that doctors worldwide say works well in combating ‘COVID.’ Watch this excellent video for the story of Ivermectin and COVID19.
Spending on tests that can be used to detect the novel coronavirus soared in Wuhan, China, several months before the first official reporting of COVID-19 cases, according to research by Australian cybersecurity firm Internet 2.0.